Three-port Versus Conventional Laparoscopic Surgery for Colorectal Cancer
Single-center Prospective Randomized Controlled Study of the Three-port Laparoscopic Surgery Versus Conventional Laparoscopic Surgery for Colorectal Cancer
1 other identifier
interventional
282
1 country
1
Brief Summary
This study is designed to evaluate the short-term and long-term results after three-port laparoscopic surgery for colorectal cancer(TLSC) compared with conventional laparoscopic surgery for colorectal cancer(CLSC).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable colorectal-cancer
Started Mar 2018
Longer than P75 for not_applicable colorectal-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2018
CompletedFirst Posted
Study publicly available on registry
February 8, 2018
CompletedStudy Start
First participant enrolled
March 25, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedFebruary 13, 2020
February 1, 2020
1.9 years
January 31, 2018
February 12, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Early morbidity rate
morbidity rate 30 days after surgery
30 days after surgery
Secondary Outcomes (10)
Operative time
intraoperative
Intraoperative blood loss
intraoperative
Lymph node detection
14 days after surgery
Proximal resection margin
14 days after surgery
Distal resection margin
14 days after surgery
- +5 more secondary outcomes
Study Arms (2)
Three-port Laparoscopic Surgery
EXPERIMENTALPatients with colorectal cancer undergo three-port laparoscopic surgery.
Conventional Laparoscopic Surgery
EXPERIMENTALPatients with colorectal cancer undergo conventional laparoscopic surgery(4 or more ports).
Interventions
Patients undergo three-port laparoscopic surgery. The surgery will be completed by a surgeon and a camera-person without another assistant. The surgeon will adjust surgical position to expose the operative field with the help of gravity. All the orther operative procedures are the same as conventional laparoscopic surgery.
Patients undergo conventional laparoscopic surgery(4 or more ports).The surgery will be routinely completed by a surgeon,a camera-person and another assistant to provide counter-traction.
Eligibility Criteria
You may qualify if:
- Body mass index (BMI) \<30 kg/m2
- Tumor located in colon and high rectum (the lower border of the tumor is above the peritoneal reflection)
- Pathological colorectal carcinoma
- Clinically diagnosed cT1-4aN0-2 M0 lesions according to the 7th Edition of AJCC Cancer Staging Manual with or without neoadjuvant therapeutic history
- ECOG score is 0-1
- ASA score is Ⅰ-Ⅲ
- Informed consent
You may not qualify if:
- Previous gastrointestinal surgery
- History of inflammatory bowel disease
- History of familial adenomatous polyposis(FAP)
- Pregnant woman or lactating woman
- Severe mental disease
- Intolerance of surgery for severe comorbidities
- Emergency operation due to complication (bleeding, perforation or obstruction) caused by colorectal cancer
- Requirement of simultaneous surgery for other disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruijin Hospitallead
Study Sites (1)
Ruijin Hospital
Shanghai, Shanghai Municipality, 200025, China
Related Publications (2)
Tawfik Amin A, Elsaba TM, Amira G. Three ports laparoscopic resection for colorectal cancer: a step on refining of reduced port surgery. ISRN Surg. 2014 Mar 12;2014:781549. doi: 10.1155/2014/781549. eCollection 2014.
PMID: 25006515BACKGROUNDSeow-En I, Tan KY, Mohd Daud MA, Seow-Choen F. Traditional laparoscopic colorectal resections can be performed effectively using a three-port technique. Tech Coloproctol. 2011 Mar;15(1):91-3. doi: 10.1007/s10151-010-0660-6. Epub 2011 Jan 14. No abstract available.
PMID: 21234638BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Tao Zhang, MD
Ruijin Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Physicion
Study Record Dates
First Submitted
January 31, 2018
First Posted
February 8, 2018
Study Start
March 25, 2018
Primary Completion
March 1, 2020
Study Completion
March 1, 2025
Last Updated
February 13, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share